These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38987479)

  • 1. Outpatient-Based Opioid Treatment Engagement and Attendance: A Prospective Cohort Study of Homeless-Experienced Adults.
    Fine DR; Hart K; Critchley N; Chang Y; Regan S; Joyce A; Tixier E; Sporn N; Gaeta J; Wright J; Kruse G; Baggett TP
    J Gen Intern Med; 2024 Jul; ():. PubMed ID: 38987479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "I'm on the Right Path": Exploring 1-Month Retention in a Homeless-Tailored Outpatient-Based Opioid Treatment Program.
    Fine DR; Critchley N; Hart K; Joyce A; Sporn N; Gaeta J; Wright J; Baggett TP; Kruse G
    Subst Use Addctn J; 2024 Apr; 45(2):268-277. PubMed ID: 38258838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Office-Based Addiction Treatment Retention and Mortality Among People Experiencing Homelessness.
    Fine DR; Lewis E; Weinstock K; Wright J; Gaeta JM; Baggett TP
    JAMA Netw Open; 2021 Mar; 4(3):e210477. PubMed ID: 33662132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Very early disengagement and subsequent re-engagement in primary care Office Based Opioid Treatment (OBOT) with buprenorphine.
    Hui D; Weinstein ZM; Cheng DM; Quinn E; Kim H; Labelle C; Samet JH
    J Subst Abuse Treat; 2017 Aug; 79():12-19. PubMed ID: 28673522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term retention in Office Based Opioid Treatment with buprenorphine.
    Weinstein ZM; Kim HW; Cheng DM; Quinn E; Hui D; Labelle CT; Drainoni ML; Bachman SS; Samet JH
    J Subst Abuse Treat; 2017 Mar; 74():65-70. PubMed ID: 28132702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Training in office-based opioid treatment with buprenorphine in US residency programs: A national survey of residency program directors.
    Tesema L; Marshall J; Hathaway R; Pham C; Clarke C; Bergeron G; Yeh J; Soliman M; McCormick D
    Subst Abus; 2018; 39(4):434-440. PubMed ID: 29513136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Overdose Mortality Among People Experiencing Homelessness, 2003 to 2018.
    Fine DR; Dickins KA; Adams LD; De Las Nueces D; Weinstock K; Wright J; Gaeta JM; Baggett TP
    JAMA Netw Open; 2022 Jan; 5(1):e2142676. PubMed ID: 34994792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient Barriers and Facilitators to Medications for Opioid Use Disorder in Primary Care.
    Tofighi B; Williams AR; Chemi C; Suhail-Sindhu S; Dickson V; Lee JD
    Subst Use Misuse; 2019; 54(14):2409-2419. PubMed ID: 31429351
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary care and medication management characteristics among patients receiving office-based opioid treatment with buprenorphine.
    Du CX; Shi J; Tetrault JM; Madden LM; Barry DT
    Fam Pract; 2022 Mar; 39(2):234-240. PubMed ID: 34893825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C treatment outcomes among homeless-experienced individuals at a community health centre in Boston.
    Beiser ME; Smith K; Ingemi M; Mulligan E; Baggett TP
    Int J Drug Policy; 2019 Oct; 72():129-137. PubMed ID: 30962036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating substance use care into primary care for adolescents and young adults: Lessons learned.
    Bagley SM; Hadland SE; Schoenberger SF; Gai MJ; Topp D; Hallett E; Ashe E; Samet JH; Walley AY
    J Subst Abuse Treat; 2021 Oct; 129():108376. PubMed ID: 34080547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating homeless opioid dependent patients with buprenorphine in an office-based setting.
    Alford DP; LaBelle CT; Richardson JM; O'Connell JJ; Hohl CA; Cheng DM; Samet JH
    J Gen Intern Med; 2007 Feb; 22(2):171-6. PubMed ID: 17356982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of full and partial opioid agonists for opioid use disorder in outpatient settings: United States healthcare sector perspective.
    Choi SA; Yan CH; Gastala NM; Touchette DR; Stranges PM
    J Subst Use Addict Treat; 2024 May; 160():209237. PubMed ID: 38061629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-Centered Outcomes Associated With a Novel Office-Based Opioid Treatment Program in a District Health Department: Mixed Methods Pilot Study.
    Coles T; Chen H; Des Marais A; Sachdeva N; Bush C; Macon Harrison L; Guthrie S
    JMIR Form Res; 2023 May; 7():e40897. PubMed ID: 37223963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engagement and Substance Dependence in a Primary Care-Based Addiction Treatment Program for People Infected with HIV and People at High-Risk for HIV Infection.
    Walley AY; Palmisano J; Sorensen-Alawad A; Chaisson C; Raj A; Samet JH; Drainoni ML
    J Subst Abuse Treat; 2015 Dec; 59():59-66. PubMed ID: 26298399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safer in care: A pandemic-tested model of integrated HIV/OUD care.
    Eaton EF; Tamhane A; Turner W; Raper JL; Saag MS; Cropsey KL
    Drug Alcohol Depend; 2022 Feb; 231():109241. PubMed ID: 35007957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of interventions to reduce homelessness: a systematic review and meta-analysis.
    Munthe-Kaas HM; Berg RC; Blaasvær N
    Campbell Syst Rev; 2018; 14(1):1-281. PubMed ID: 37131370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Hospital Adoption of an Emergency Department Treatment Pathway for Opioid Use Disorder and Patient Initiation of Buprenorphine After Discharge.
    Solomon KT; O'Connor J; Gibbons JB; Kilaru AS; Feder KA; Xue L; Saloner B; Stuart EA; Cole ES; Hulsey E; Meisel Z; Patel E; Donohue JM
    JAMA Health Forum; 2023 Mar; 4(3):e230245. PubMed ID: 36961457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of hepatitis C treatment initiation and retention in office-based opioid treatment with buprenorphine: a retrospective cohort study.
    Geist ML; Radick AC; Tsui JI; Blalock KL; Adwell A; Tamru E; Connolly NC; James JR
    Addict Sci Clin Pract; 2023 May; 18(1):33. PubMed ID: 37231486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staff Attitudes toward Buprenorphine before and after Implementation of an Office-Based Opioid Treatment Program in an Urban Teaching Clinic.
    James JR; Marolf M; Klein JW; Blalock KL; Merrill JO; Tsui JI
    Subst Use Misuse; 2021; 56(11):1569-1575. PubMed ID: 34282999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.